Go Back

Panda Perspectives

Delivering candid conversations with influential healthcare leaders, offering a look at the strategies, challenges, and passions that are driving meaningful change in the industry.

Panda Perspectives

David Clayton

MarketScale
December 17, 2024

In this Panda Perspectives episode, Duke Health’s David Claxton shares insights on measuring digital health ROI, drawing from his experience in both health systems and as a former digital health vendor. He discusses challenges in validating ROI claims, the importance of realistic vendor partnerships, and the surprising under-prioritization of clinic time savings. David highlights Duke’s AI-driven efforts to improve provider workflows, reduce burnout, and enhance patient care, emphasizing the need for trust, collaboration, and tangible outcomes in digital health adoption.

Recent Episodes

CtUC 2025
View episode

Elevating the Standards Together: What We Are Looking Forward to at CtUC 2025

The sterile processing industry stands at a pivotal moment. With surgical case volumes rising while departmental resources remaining flat, the pressure to “do more with less” has never been greater. Nowadays, sterile processing departments (SPDs) are struggling with high staff turnover and growing compliance requirements. And while these regulations are designed to improve patient…

Burl Stamp
View episode

Improving Employee Engagement Through CAREmunication — A Conversation with Burl Stamp

With the healthcare landscape seeing many evolving changes, employee engagement is no longer just a buzzword — it’s now a business imperative. Amid rising turnover and persistent staffing shortages, organizations are under pressure to build resilient, engaged teams. According to Gallup, 70% of the variance in team engagement is tied to one factor: the…

precision machining
View episode

Pharma Manufacturing: Meeting Annex I with Precision Machining for Safer Sterile Drug Production

Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert